MRK stock soars as Keytruda delivers again in Q1, Winrevair accelerates — CEO signals robust phase 3 readout period ahead

MRK stock soars as Keytruda delivers again in Q1, Winrevair accelerates — CEO signals robust phase 3 readout period ahead  MSN

Summary aggregated from MSN's public RSS feed. The full reporting belongs to MSN — please read it on their site.